Dietary intake of Cruciferous vegetables, Glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population Lisa I. WangEdward L. GiovannucciDavid C. Christiani OriginalPaper Pages: 977 - 985
Trends in breast cancer mortality rates by region of the United States, 1950–1999 Susan R. SturgeonCatherine SchairerSusan Devesa OriginalPaper Pages: 987 - 995
Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births Daniel R. BrooksLorelei A. MucciSven Cnattingius OriginalPaper Pages: 997 - 1005
A case–control study of occupational risk factors for bladder cancer in Canada Reimar R. W. GaertnerLjiljana TrpeskiKenneth C. Johnson OriginalPaper Pages: 1007 - 1019
The incidence of cancer in people with intellectual disabilities Sheena G. SullivanRafat HussainAlan H. Bittles OriginalPaper Pages: 1021 - 1025
How representative are the surveillance, epidemiology, and end results (SEER) Program cancer data of the United States? Ray M. MerrillKirk A. Dearden OriginalPaper Pages: 1027 - 1034
Exercise interventions for cancer patients: systematic review of controlled trials Clare StevinsonDebbie A LawlorKenneth R Fox OriginalPaper Pages: 1035 - 1056
Rationale and design of the National Program of Cancer Registries' breast, colon, and prostate cancer patterns of care study Kathleen McDavidMaria J. SchymuraSusan Bolick-Aldrich OriginalPaper Pages: 1057 - 1066
Alcohol intake and risk of non-Hodgkin lymphoma in men and women Ellen T. ChangKarin Ekström SmedbyBengt Glimelius OriginalPaper Pages: 1067 - 1076
Polymorphic variation of CYP1A1 is associated with the risk of gastric cardia cancer: a prospective case–cohort study of cytochrome P-450 1A1 and GST enzymes Mark J. RothChristian C. AbnetYou-Lin Qiao OriginalPaper Pages: 1077 - 1083
Association of folate and alcohol with risk of ovarian cancer in a prospective study of postmenopausal women Linda E. KelemenThomas A. SellersJames R. Cerhan OriginalPaper Pages: 1085 - 1093
Prospective study of plasma enterolactone and prostate cancer risk (Sweden) Pär StattinAnnika BylundHerman Adlercreutz OriginalPaper Pages: 1095 - 1102